Abstract

Background

Globally, acute asthma flare-ups continue to be a leading cause of pediatric ER visits and hospital stays. The predominant triggering factor, especially in severe episodes and status asthmaticus, is known to be viral respiratory infections. Via intricate immunological and epithelial processes, pathogens such respiratory syncytial virus (RSV), rhinovirus, influenza virus, and more recently SARS - CoV - 2 cause airway inflammation. It is crucial to comprehend these viral triggers in order to enhance child control and prevention tactics.Using the PubMed, Scopus, and Embase databases.

Methods

A narrative review of pediatric-focused literature published between 2010 and 2025 was carried out. Included were studies looking at immunologic pathways, clinical outcomes in children, viral infections, and the intensity of asthma flare-ups.

Results

While RSV is closely linked to early-life wheeze and long-term asthma risk, rhinovirus is the most common viral cause of severe pediatric asthma exacerbations. Seasonal increases in severe asthma presentations are partly caused by influenza infection. According to new research, immunological dysregulation and structural airway alterations brought on by post - COVID airway inflammation may increase the severity of asthma. Increased type -2 inflammation, compromised interferon responses, and epithelial damage are common factors.

Conclusions

A major contributing factor to children severe asthma and status asthmaticus is viral infections. Individualized asthma treatment, early detection of virus-induced exacerbations, and preventive vaccination are essential. To better understand the pulmonary effects of COVID -19 in children, longitudinal study is required. 

Introduction

The most prevalent long-term respiratory condition in children and a major contributor to avoidable hospital stays is asthma. Acute exacerbations continue to be a chronic clinical problem, despite the fact that many children attain adequate symptom management with maintenance medication. Severe bouts, especially status asthmaticus, can worsen quickly and necessitate critical care. The bulk of these severe occurrences are preceded by viral respiratory infections, a finding that is consistent across epidemiologic research ( GINA, 2024 ).

Children's airways are particularly vulnerable to viral damage. The clinical effects of viral exposure are increased by immature immune responses, restricted airway diameter, and increased inflammatory reactivity. RSV and rhinovirus are two respiratory viruses that have long been linked to kid and infant wheezing disorders ( Jackson et al., 2013 ). Seasonal increases in severe asthma admissions are a result of influenza, particularly in children who have not received the vaccination ( Kloepfer & Gern, 2016 ). Concerns about chronic airway inflammation and altered immune modulation after infection have been brought up more recently by SARS - CoV - 2.

Although viral triggers have been identified, pediatric practice frameworks still do not fully incorporate their relative roles and mechanisms in causing potentially fatal asthma attacks. Early intervention, vaccine priority, and prevention tactics all benefit from an understanding of these pathways.

With a focus on immunopathology and clinical implications, this study investigates the roles that RSV, rhinovirus, influenza, and post - COVID airway alterations play in children's severe asthma exacerbations and status asthmaticus. 

Methods

To assess the connection between viral infections and severe asthma exacerbations in pediatric populations, a narrative literature synthesis was carried out.

Keyword combinations including pediatric asthma, viral exacerbation, RSV, rhinovirus, influenza, COVID - 19, and status asthmaticus were used to search electronic databases such as PubMed, Scopus, and Embase for research published between January 2010 and January 2025.

Inclusion criteria

1)      Human research with minors under the age of 18

2)      Studies relating hospitalization or the severity of asthma to viral infection

3)      Mechanistic or immunologic studies related to inflammation of the airways

4)      Peer-reviewed publications

Exclusion criteria

1)  Adult - only populations

2)  Non - English publications

3)  Small case reports lacking outcome data

Relevant articles were screened and categorized by viral pathogen. Due to heterogeneity in study design, findings were synthesized narratively, focusing on clinical applicability and biological plausibility. 

Results

Eighty-two papers were categorized by viral pathogen (RSV, rhinovirus, influenza, and SARS - CoV - 2) after meeting inclusion criteria. Increased asthma severity, hospitalization risk, and indicators of airway inflammation were all significantly correlated with viral infection in all groups.

Respiratory Syncytial Virus and Early Airway Vulnerability

RSV is a well-known precursor to recurrent wheezing and a major cause of lower respiratory tract infections in infants. According to longitudinal cohort studies, infants hospitalized with RSV bronchiolitis are much more likely to experience childhood asthma and persistent wheezing (Sigurs et al., 2010).

RSV increases eosinophilic inflammation and mucus hypersecretion by compromising epithelial integrity and inducing a Th2 - skewed immune response. RSV infection often causes severe exacerbations that necessitate hospitalization in children with preexisting asthma. The severity of the disease over time may be increased by repeated viral damage, which may also lead to airway remodeling.

Rhinovirus: Dominant Trigger of Severe Exacerbations

The most frequent viral cause of asthma flare-ups in school-age children is rhinovirus. Most severe attacks needing emergency care are preceded by rhinovirus infection, according to prospective surveillance studies ( Jackson et al., 2013 ).

According to Contoli et al. (2006), children with asthma exhibit compromised interferon responses to rhinovirus, which results in prolonged viral replication and increased inflammatory signaling. Severe clinical manifestations and enhanced pathogenicity are linked to specific genotypes, especially RV - C.

Airway inflammation is further increased by the combination of viral infection and allergic sensitization. When atopic children are exposed to rhinovirus, their cytokine release, airway hyperresponsiveness, and symptom severity all increase synergistically.

Influenza and Seasonal Exacerbation Patterns

Predictable winter surges in pediatric asthma hospitalizations are partly caused by influenza. Influenza causes both direct airway damage and systemic inflammatory reactions, in contrast to rhinovirus. Following an influenza infection, children with asthma had higher symptom burdens, higher hospitalization rates, and longer recovery times ( Foley et al., 2017 ).

Although vaccination lowers the incidence of influenza and asthma-related complications, uptake in high-risk pediatric populations is still below optimum levels. During influenza outbreaks, secondary bacterial infections and increased airway responsiveness exacerbate the severity of the illness.

Post-COVID Airway Inflammation

Although acute SARS - CoV -2 infection in children is typically mild, new research indicates that some patients may experience long-term respiratory consequences. Coughing, activity intolerance, and wheezing are post - COVID symptoms, especially in children who already have asthma ( Whitaker et al., 2022 ).

Immunologic research shows that after infection, there is persistent interferon activation and T-cell dysregulation, which may compromise antiviral defense and encourage chronic inflammation. In certain cases, imaging and physiologic evaluations show mild airway remodeling.

These results raise concerns that SARS - CoV-2 may act as a modulator of asthma severity rather than a simple temporary trigger, even though long-term pediatric data are still few.

Comparative Mechanisms of Viral-Induced Exacerbation

Despite characteristics unique to each disease, common pathways include:

l  Disruption of the epithelial barrier

l  Reduced interferon signaling against viruses

l  Increased inflammation of type 2

l  Enhanced hyperresponsiveness of the airways

The rapid escalation of symptoms typical of status asthmaticus is caused by the convergence of these routes.

Discussion

This summary emphasizes how viral infections are the primary cause of severe asthma flare-ups in children. While RSV contributes to early-life airway sensitivity, rhinovirus is the most common cause, especially in atopic children. SARS - CoV - 2 raises new concerns about long-term airway health, while influenza continues to be a significant seasonal risk.

Impaired antiviral immunity is a major theme. Deficient interferon responses are common in children with asthma, which permits extended viral persistence and severe inflammation. Viral exposure is a powerful amplifier of bronchial hyperreactivity when coupled with allergic airway illness.

Prevention continues to be the best approach from a clinical standpoint. Exacerbation risk is decreased by influenza vaccination, infection management strategies, and controller therapy compliance. Treatment with bronchodilators and anti inflammatory drugs can be promptly intensified when virus-induced deterioration is detected early.

More complexity is introduced in the post COVID era. Clinicians should keep an eye out for prolonged respiratory symptoms in children recovering from SARS CoV - 2 infection, even if conclusive causative routes are still being examined.

Limitations

This review is constrained by heterogeneity in study design and reliance on observational data. Mechanistic findings may not translate uniformly across pediatric subgroups. Long term post COVID outcomes remain incompletely characterized.

Future Directions

Key priorities include:

Ø  Longitudinal pediatric studies on viral – asthma interactions

Ø  Biomarkers predicting severe virus induced exacerbations

Ø  Targeted immunomodulatory therapies

Ø  Expanded vaccination strategies

Understanding host – virus dynamics may allow precision prevention and individualized care.

Conclusion

Children's status asthmaticus and severe asthma flare-ups are primarily caused by viral respiratory infections. Influenza, SARS-CoV-2, RSV, and rhinovirus all have similar but different inflammatory effects that worsen airway dysfunction. Reducing morbidity requires combining early intervention techniques, optimal asthma care, and preventive immunization. In the coming years, pediatric asthma management will be improved by ongoing research into immunological mechanisms and post-viral airway alterations.

References

1.   Akinbami, L. J., et al. (2012). Asthma prevalence and healthcare use. Journal of Allergy and Clinical Immunology.

2.   Contoli, M., et al. (2006). Deficient interferon production in asthma. Nature Medicine.

3.   Foley, D. H., et al. (2017). Influenza and pediatric asthma. Journal of Infectious Diseases.

4.   Global Initiative for Asthma. (2024). Global strategy for asthma management.

5.   Jackson, D. J., et al. (2013). Rhinovirus illnesses and asthma exacerbations. New England Journal of Medicine.

6.   Kloepfer, K. M., & Gern, J. E. (2016). Viral triggers of asthma. Allergy.

7.   Sigurs, N., et al. (2010). RSV bronchiolitis and childhood asthma. Pediatrics.

8.   Whitaker, M. J., et al. (2022). Post-COVID respiratory symptoms in children. Pediatric Infectious Disease Journal.

9.   Busse, W. W., Lemanske, R. F., & Gern, J. E. (2010). Role of viral respiratory infections in asthma. The Lancet, 376(9743), 826–834.

10. Gern, J. E. (2015). Viral respiratory infection and the link to asthma. Pediatric Infectious Disease Journal, 34(10), S16–S18.

11. Jartti, T., et al. (2012). Viral infections and asthma exacerbations in children. European Respiratory Journal, 40(4), 895–906.

12. Khetsuriani, N., et al. (2007). Viral respiratory infections in children with asthma. Journal of Allergy and Clinical Immunology, 119(2), 314–321.

13. Papadopoulos, N. G., et al. (2011). Viruses and asthma exacerbations. Allergy, 66(4), 458–468.

14. Kusel, M. M., et al. (2007). Early viral infections and asthma risk. The Lancet, 370(9583), 254–261.

15. Gern, J. E., & Busse, W. W. (2002). Relationship of viral infections to wheezing illnesses. Journal of Allergy and Clinical Immunology, 110(6), S92–S98.

16. Miller, E. K., et al. (2009). Rhinovirus-associated hospitalizations in children. Journal of Infectious Diseases, 199(8), 1097–1105.

17. Mansbach, J. M., et al. (2012). Severe bronchiolitis and future asthma. Pediatrics, 130(6), e1528–e1535.

18. Jartti, T., & Gern, J. E. (2017). Rhinovirus and asthma. Journal of Allergy and Clinical Immunology, 140(4), 895–906.

19. Kloepfer, K. M., et al. (2014). Viral respiratory infections in pediatric asthma. Clinical Microbiology Reviews, 27(4), 722–742.

20. Papadopoulos, N. G. (2012). Mechanisms of virus-induced asthma. Current Opinion in Allergy and Clinical Immunology, 12(1), 1–7.

21. Gern, J. E., et al. (2012). Interferon responses in asthma. Journal of Allergy and Clinical Immunology, 130(3), 556–562.

22. Johnston, S. L. (2007). Overview of virus-induced airway disease. Thorax, 62(1), 1–3.

23. Edwards, M. R., et al. (2013). Viral infections and airway inflammation. European Respiratory Journal, 42(2), 503–515.

24. Lukkarinen, M., et al. (2019). Rhinovirus species and asthma severity. Pediatric Allergy and Immunology, 30(3), 272–280.

25. Jartti, T., et al. (2015). Role of viruses in asthma pathogenesis. Pediatric Respiratory Reviews, 16(2), 86–91.

26. Grayson, M. H., et al. (2015). Immune responses to viral infection in asthma. American Journal of Respiratory Cell and Molecular Biology, 52(2), 144–149.

27. Papadopoulos, N. G., & Johnston, S. L. (2001). Virus-induced asthma mechanisms. Thorax, 56(11), 938–945.

28. Rubner, F. J., et al. (2017). Early-life viral wheezing and asthma development. Lancet Respiratory Medicine, 5(12), 915–924.